Interactive Transcript
0:00
This is our last case, a patient
0:02
with a posterior knee mass.
0:03
So we're gonna stay in the popal region.
0:06
Uh, this patient came with outside workup,
0:08
had an ultrasound,
0:10
and they found this, uh,
0:11
vascularized mass at the popal region.
0:14
This was subsequently biopsied
0:16
and, uh, referred to us for further, um, management.
0:22
And so this is the patient's MR Imaging,
0:25
and you can see this pop teal mass.
0:28
And we have a combination. This is a PD fat
0:30
sat, uh, sequence.
0:32
This is a T one fat sat sequence without contrast
0:35
and post contrast sequence here.
0:37
And we can see that there is this enhancing mass in the pop
0:40
teal region between the medial
0:42
and lateral heads of the gastrocnemius muscles.
0:45
You always wanna make sure that you're not dealing
0:47
with something like a popliteal cyst, which is one
0:50
of the more common masses
0:51
that you encounter at the back of the knee.
0:53
Ideally, again, should emanate from
0:55
between the semimembranosus tendon, the medial head
0:58
of the gastroc anemia tendon.
0:59
But clearly this is not a cyst.
1:02
This is a mass that has solid enhancement.
1:05
And, and whenever you're doing tumor imaging,
1:07
it's always important to have a T one fat suppress sequence
1:10
before you give gad
1:11
because you can see that there's some intrinsic T one
1:14
shortening in this mass representing blood products, uh,
1:19
or extracellular meth hemoglobin
1:22
when we're working up any mass too.
1:24
We also want to identify its relationship
1:26
with neurovascular structures.
1:27
So you can see it's, it's intimate with the popliteal artery
1:31
and the vein right in front of it,
1:33
but look what's right behind it.
1:34
We can see that the tibial nerve is also plastered along the
1:38
posterior and posterior medial aspect of this mass.
1:42
Now, given the heterogeneity of this, uh, mass, uh,
1:47
most of you probably know what this entity ended up being.
1:49
This was indeed a synovial sarcoma.
1:53
And some of the imaging features, um,
1:54
include a heterogeneous appearance, sometimes referred to
1:58
as a triple sign, where you have alternating areas
2:00
of bright, intermediate and low signal.
2:02
The bright and intermediate signal represent cystic
2:05
degeneration and blood products.
2:07
And the areas of low signal often represent fibrous bands.
2:10
Not always seen universal universally
2:12
and synovial sarcomas, uh, but can be seen.
2:16
The other sign that you might see is called the bunch
2:18
of grape sign, multiple lobular masses
2:20
that look like, uh, grapes.
2:23
So this patient underwent, uh, neoadjuvant radiation therapy
2:28
to try to get this mass to shrink a little bit.
2:31
And I'll just kind of show you
2:33
what it looked like afterwards.
2:34
Let me give you just the post contrast sequence
2:37
and let me see if I can match these up a little bit.
2:41
So here's the sagittal, pre neoadjuvant.
2:45
Here is the post,
2:47
and you can see in fact it actually grew a little bit.
2:49
The whole point of neoadjuvant, uh, surgery,
2:53
or excuse me, neoadjuvant radiation therapy is
2:55
to reduce the mass to make surgery a little bit easier for
2:58
Our surgical colleagues.
3:00
Now, you could argue is this really bigger
3:03
because you can see that there's more enha non enhancing
3:06
components centrally within this lesion.
3:08
So saying that's a little bit, uh, bigger is um, uh,
3:12
a little bit tricky because clearly this has undergone some
3:15
degree of necrosis, which means that indeed it is responding
3:20
to the neoadjuvant therapy.
3:22
So you always have to kind
3:23
of give a caveat if you say a mass is bigger,
3:26
if there's necrosis.
3:27
You also wanna mention that as well.
3:28
'cause that means that this in some way is actually
3:31
positively responding to neoadjuvant therapy.
3:34
So, um, because of the difficulty of surgery, trying
3:39
to peel this off of the neurovascular structures,
3:41
this patient elected for above the knee amputation
3:44
and unfortunately de developed pulmonary metastasis
3:47
after surgery.